Methotrexate Hepatotoxicity
What is Methotrexate Hepatotoxicity?
Methotrexate hepatotoxicity is liver damage caused by taking methotrexate, a medication commonly used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions. This medication works by slowing down certain cells in your body, including those in your liver. Over time, methotrexate can harm liver cells and lead to scarring.
The liver is your body's main filter and detox organ. It processes medications, removes waste, and makes proteins your body needs. When methotrexate damages liver cells, the organ cannot do these jobs as well. Most people develop mild liver inflammation at first. Without monitoring, this inflammation can progress to fibrosis, where scar tissue builds up, or even cirrhosis, where severe scarring affects liver function.
The good news is that methotrexate hepatotoxicity is usually preventable with regular blood testing. Catching liver changes early allows your doctor to adjust your dose or stop the medication before serious damage occurs. Most cases are mild and reversible when detected through routine monitoring.
Symptoms
- Fatigue or feeling unusually tired
- Nausea or loss of appetite
- Pain or discomfort in the upper right abdomen
- Dark urine or pale stools
- Yellowing of the skin or eyes, called jaundice
- Itchy skin
- Swelling in the legs or abdomen
- Easy bruising or bleeding
Many people with early methotrexate hepatotoxicity have no symptoms at all. Liver damage can develop silently over months or years. This is why regular blood testing is essential for anyone taking methotrexate, even if you feel perfectly fine.
Concerned about Methotrexate Hepatotoxicity? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Methotrexate hepatotoxicity is caused by the direct toxic effect of methotrexate on liver cells. The medication accumulates in the liver and can damage hepatocytes, the main working cells of the liver. This damage happens more often with higher doses and longer treatment duration. People who take methotrexate daily or for many years face higher risk than those on weekly low-dose regimens.
Several factors increase your risk of developing liver damage while on methotrexate. Drinking alcohol adds stress to the liver and sharply raises toxicity risk. Obesity, diabetes, and preexisting liver disease also make hepatotoxicity more likely. Taking other medications that affect the liver, such as certain antibiotics or pain relievers, can increase the burden on this organ. Older age and kidney problems may slow how your body clears methotrexate, leading to buildup. Your genetics may also play a role in how your liver processes this medication.
How it's diagnosed
Methotrexate hepatotoxicity is diagnosed primarily through blood tests that measure liver enzymes. The most important marker is alanine aminotransferase, or ALT, which leaks into your blood when liver cells are damaged. Your doctor will order ALT tests before you start methotrexate and then regularly throughout treatment, usually every 4 to 12 weeks. Rising ALT levels signal liver injury and may prompt your doctor to reduce your dose or stop the medication temporarily.
Rite Aid offers convenient ALT testing through our blood testing service at Quest Diagnostics locations nationwide. Regular monitoring helps catch liver changes early, before symptoms appear. If ALT levels stay elevated or rise significantly, your doctor may order additional tests such as a liver ultrasound or biopsy. These procedures help determine the extent of liver damage and guide treatment decisions.
Treatment options
- Reducing your methotrexate dose or temporarily stopping the medication
- Avoiding alcohol completely while on methotrexate therapy
- Maintaining a healthy weight through balanced nutrition and regular physical activity
- Managing diabetes and other metabolic conditions that stress the liver
- Reviewing all medications and supplements with your doctor to avoid additional liver burden
- Taking folic acid supplements, which may help reduce methotrexate side effects
- Switching to a different medication if liver damage continues or worsens
- Working with a hepatologist, or liver specialist, for advanced cases
Most cases of methotrexate hepatotoxicity improve when the medication is stopped or the dose is reduced. Early detection through regular ALT monitoring gives your liver time to heal before permanent scarring develops.
Concerned about Methotrexate Hepatotoxicity? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Methotrexate hepatotoxicity is liver damage caused by taking the medication methotrexate. This drug is commonly used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions. Over time, methotrexate can harm liver cells, leading to inflammation, scarring, and reduced liver function.
Mild liver enzyme elevations occur in up to 30% of people taking methotrexate. However, serious liver damage such as fibrosis or cirrhosis is much less common, affecting fewer than 5% of patients. Regular blood test monitoring helps catch problems early and prevents progression to severe damage.
Most people have no symptoms when liver damage begins. Blood tests often detect elevated ALT levels before you feel anything wrong. When symptoms do appear, they may include fatigue, nausea, loss of appetite, or discomfort in the upper right abdomen.
Most doctors recommend ALT testing every 4 to 12 weeks during methotrexate therapy. Your doctor may test more frequently when you first start the medication or if your ALT levels rise. Regular monitoring is essential for catching liver damage early, even if you feel fine.
No, you should avoid alcohol completely while on methotrexate therapy. Alcohol adds significant stress to your liver and greatly increases the risk of hepatotoxicity. Even small amounts of alcohol can raise your risk of serious liver damage when combined with methotrexate.
ALT is an enzyme found inside liver cells. When liver cells are damaged, ALT leaks into your bloodstream and blood levels rise. Elevated ALT during methotrexate therapy signals that the medication may be harming your liver and your dose may need adjustment.
Yes, most cases of methotrexate hepatotoxicity are reversible if caught early. When the medication is stopped or the dose is reduced, ALT levels often return to normal and the liver heals. However, advanced fibrosis or cirrhosis may cause permanent damage.
If your ALT levels remain elevated, your doctor may temporarily stop methotrexate to let your liver recover. You may also need additional tests such as an ultrasound or liver biopsy. Your doctor might switch you to a different medication or adjust other risk factors like weight or diabetes control.
Regular blood test monitoring is the best prevention strategy. Avoiding alcohol, maintaining a healthy weight, managing diabetes, and taking folic acid supplements may also help protect your liver. Tell your doctor about all medications and supplements you take to avoid additional liver stress.
People who drink alcohol, have obesity, have diabetes, or have preexisting liver disease face the highest risk. Older adults and those with kidney problems also have increased risk. Taking higher doses of methotrexate or using it for many years raises your risk of liver damage.